rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-7-25
|
pubmed:abstractText |
This study reports the efficacy of a heterologous prime-boost vaccination using DNA and vaccinia viruses (Western Reserve [WR] virus and modified [attenuated] vaccinia virus Ankara [MVA]) expressing the LACK antigen (Leishmania homologue of receptors for activated C kinase) and an intradermal murine infection model employing Leishmania infantum. At 1 month postinfection, vaccinated mice showed high levels of protection in the draining lymph node (240-fold reduction in parasite burden) coupled with significant levels of gamma interferon (20 to 200 ng/ml) and tumor necrosis factor alpha/lymphotoxin (8 to 134 pg/ml). Significant but lower levels of protection (6- to 30-fold) were observed in the spleen and liver. Comparable levels of protection were found for mice boosted with either LACK-WR or LACK-MVA, supporting the use of an attenuated vaccinia virus-based vaccine against human visceral leishmaniasis.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-10458764,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-10507299,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-10652464,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-10725726,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11035737,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11166894,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11294678,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11312013,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11349082,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11447143,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11543670,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11567746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11592059,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11738764,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-11803085,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12088641,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12150849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12443660,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12450700,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12456849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12496190,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12650765,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12706707,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12744881,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-12819086,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-14500669,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-14529359,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-14551897,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-14978115,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-15003644,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-15016878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-15140980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-2104889,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-2351828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-3104456,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-3918107,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-7694973,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-7725103,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-8021511,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-8450215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-8780448,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-8876137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-9162526,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-9521077,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-9989990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16041057-9990343
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0019-9567
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5286-9
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16041057-Animals,
pubmed-meshheading:16041057-Antigens, Protozoan,
pubmed-meshheading:16041057-Immunization, Secondary,
pubmed-meshheading:16041057-Interferon-gamma,
pubmed-meshheading:16041057-Leishmania infantum,
pubmed-meshheading:16041057-Leishmaniasis, Visceral,
pubmed-meshheading:16041057-Mice,
pubmed-meshheading:16041057-Mice, Inbred BALB C,
pubmed-meshheading:16041057-Protozoan Proteins,
pubmed-meshheading:16041057-Protozoan Vaccines,
pubmed-meshheading:16041057-Spleen,
pubmed-meshheading:16041057-Tumor Necrosis Factor-alpha,
pubmed-meshheading:16041057-Vaccinia virus
|
pubmed:year |
2005
|
pubmed:articleTitle |
Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis.
|
pubmed:affiliation |
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|